arterial spin-labelling), and WM integrity (diffusion tensor imaging (DTI)) compared to controls, and associations with birthweight.
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Background: Several Victorian non-tertiary (NT) centres provide nasal Continuous Positive Airway Pressure (nCPAP) to mid/-late pre-term and term neonates. State guidelines provide structure for safe practice and prompt transfer.
Aim: To compare neonates receiving nCPAP in NT and tertiary (T) centres.
Methods: Five year retrospective study (2010) (2011) (2012) (2013) (2014) . All NT eligible neonates (≥32 weeks, ≥1500 g receiving nCPAP for respiratory distress within first 24 hours) from four sites were compared with similar randomised cohort of inborn neonates at two T centres. Non-parametric analysis conducted using SPSSv24.
Results: Total subjects 1085: NT (n=484), T (n=601). One NT had larger numbers of eligible babies and higher proportion of term babies which skewed randomised T subjects, leading to difference in birth gestation 32-33 weeks (NT21% / T32%), 34-36 weeks (NT35% / T37%) and 37+ weeks (NT44% / T31%; p<0.001). No difference in gender (male NT61% / T60%); born on a weekend (NT21% / T22%); born overnight (NT24% / T27%); or antenatal steroid (32-33 week sub-group NT82% / T79%). T had more multiple gestation (T25% / NT13%). NT had poorer condition at birth: 5 minute APGAR <7 (NT22.5% / T13.5% p<0.001); fetal distress (NT29% / T18% p<0.001); no difference in meconium-stained liquor (NT13.7% / T13.1%); IPPV & ECC (NT4% / T1%; p<0.002). No difference in admission temperature, first blood glucose and lactate. NT more likely to receive chest X-ray (NT85% / T70%; p<0.001) and higher reported moderate or severe respiratory distress syndrome (NT10.8% / T3.9%).
Conclusions: Despite older gestation, NT neonates were born in poorer condition. Background: Vancomycin is commonly used in neonatal antimicrobial regimens to treat coagulase negative staphylococcal infections. Different regimens are currently used across NICU in Australasia, creating variation in dosing schedules and adjustments. The aim was to optimise vancomycin management in a NICU setting through development of a new dose adjustment guideline.
VANCOMYCIN DOSE MANAGEMENT IN NEONATES
Methods: A first-order elimination dose adjustment algorithm was developed following a literature review of current guidelines and consultation with medical and academic staff. Neonates admitted to NICU for confirmed sepsis and treated with vancomycin from 2012-2016 (48) were included in the study and 163 levels were performed. Levels performed following a dose adjustment (91) were analysed to determine the proportion of the cohort that achieved target concentration (15-20mg/L). The proposed guideline was retrospectively applied to determine the proportion of the cohort that would, theoretically, have achieved target concentration with adjustment informed by the guideline.
Results: 39 (42.9%) of vancomycin levels were below target concentration. After a clinically informed dose adjustment was applied, 13 (33.3%) achieved target concentration. When the proposed guideline was applied to the same group, 24 (61.5%) would theoretically have achieved target concentration.
Conclusion: The application of the proposed guideline demonstrated a near two fold increase in the proportion of dose adjustments that would achieve target concentrations. This proposed guideline appears to be useful in optimising vancomycin therapy, warranting prospective evaluation in neonates with confirmed sepsis where vancomycin is indicated. Background: Proteome analysis of bronchoalveolar lung fluid (BALF) has been used to obtain insight into the pathogenesis of adult lung disease but has rarely been employed in studies of the ventilated preterm lung. We aimed to analyse BALF samples from extremely preterm and preterm ventilated lambs to delineate the impact of gestational age on the lung proteome response to ventilation.
BRONCHOALVEOLAR LUNG FLUID (BALF) PROTEOMICS REVEALS COMMON AND GESTATIONAL-SPECIFIC PROTEOME ALTERATIONS ASSOCIATED WITH MECHANICAL VENTILATION

